Inhibition of histone deacetylase-induced myocardial repair is mediated by c-kit in infarcted hearts

Journal of Biological Chemistry

Volumn 287, Issue 47, 2012, Pages 39338-39348

  Zhang, Ling ^a   Chen, Bing ^b   Zhao, Yu ^b   Dubielecka, Patrycja M ^b   Wei, Lei ^a   Qin, Gang J ^c   Chin, Y Eugene ^a   Wang, Yigang ^d   Zhao, Ting C ^b  

^a BROWN UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; HEART; MAMMALS; REPAIR; STEM CELLS; TRANSCRIPTION;

CARDIAC REMODELING; FUNCTIONAL IMPROVEMENTS; FUNCTIONAL RECOVERY; GENE TRANSCRIPTIONS; HISTONE DEACETYLASES; LEFT ANTERIOR DESCENDING ARTERIES; MYOCARDIAL INFARCTION; NEO-VASCULARIZATION;

RESTORATION;

ALPHA SMOOTH MUSCLE ACTIN; BROXURIDINE; BUPRENORPHINE; HISTONE DEACETYLASE; PENTOBARBITAL; STEM CELL FACTOR RECEPTOR; TRICHOSTATIN A; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; MUSCLE PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC STEM CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; HEART FUNCTION; HEART INFARCTION; HEART VENTRICLE REMODELING; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROVASCULATURE; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TISSUE REPAIR; ANGIOGENESIS; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; HEART MUSCLE; HEART MUSCLE CELL; METABOLISM; MOUSE MUTANT; PATHOLOGY; REGENERATION; TIME;

ANIMALS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; MALE; MICE; MICE, MUTANT STRAINS; MUSCLE PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-KIT; REGENERATION; TIME FACTORS;

EID: 84873961120     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.379115     Document Type: Article

References (32)

1. Verdin, E., Dequiedt, F., and Kasler, H. G. (2003) Class II histone deacetylases. Versatile regulators. Trends Genet. 19, 286-293
2. Vigushin, D. M., and Coombes, R. C. (2004) Targeted histone deacetylase inhibition for cancer therapy. Curr. Cancer Drug Targets 4, 205-218
3. Cheung, P., Allis, C. D., and Sassone-Corsi, P. (2000) Signaling to chromatin through histone modifications. Cell 103, 263-271
4. Hansen, J. C., Tse, C., and Wolffe, A. P. (1998) Structure and function of the core histone N termini. More than meets the eye. Biochemistry 37, 17637-17641
5. Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., and Richmond, T. J. (1997) Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389, 251-260
6. Strahl, B. D., and Allis, C. D. (2000) The language of covalent histone modifications. Nature 403, 41-45
7. Turner, B. M. (2000) Histone acetylation and an epigenetic code. BioEssays 22, 836-845
8. Antos, C. L., McKinsey, T. A., Dreitz, M., Hollingsworth, L. M., Zhang, C. L., Schreiber, K., Rindt, H., Gorczynski, R. J., and Olson, E. N. (2003) Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J. Biol. Chem. 278, 28930-28937
9. Kee, H. J., Sohn, I. S., Nam, K. I., Park, J. E., Qian, Y. R., Yin, Z., Ahn, Y., Jeong, M. H., Bang, Y. J., Kim, N., Kim, J. K., Kim, K. K., Epstein, J. A., and Kook, H. (2006) Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation 113, 51-59
10. Kong, Y., Tannous, P., Lu, G., Berenji, K., Rothermel, B. A., Olson, E. N., and Hill, J. A. (2006) Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113, 2579-2588
11. Granger, A., Abdullah, I., Huebner, F., Stout, A., Wang, T., Huebner, T., Epstein, J. A., and Gruber, P. J. (2008) Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J. 22, 3549-3560
12. Lee, T. M., Lin, M. S., and Chang, N. C. (2007) Inhibition of histone deacetylase on ventricular remodeling in infarcted rats. Am. J. Physiol. Heart. Circ. Physiol. 293, H968-H977
13. Zhao, T. C., Cheng, G., Zhang, L. X., Tseng, Y. T., and Padbury, J. F. (2007) Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. Cardiovasc. Res. 76, 473-481
14. Zhao, T. C., Zhang, L. X., Cheng, G., and Liu, J. T. (2010) gp-91 mediates histone deacetylase inhibition-induced cardioprotection. Biochim. Biophys. Acta 1803, 872-880
15. Zhang, L. X., Zhao, Y., Cheng, G., Guo, T. L., Chin, Y. E., Liu, P. Y., and Zhao, T. C. (2010) Targeted deletion of NF-κB p50 diminishes the cardioprotection of histone deacetylase inhibition. Am. J. Physiol. Heart. Circ. Physiol. 298, H2154-H2163
16. Cimini, M., Fazel, S., Zhuo, S., Xaymardan, M., Fujii, H., Weisel, R. D., and Li, R. K. (2007) c-kit dysfunction impairs myocardial healing after infarction. Circulation 116, I77-82
17. Ayach, B. B., Yoshimitsu, M., Dawood, F., Sun, M., Arab, S., Chen, M., Higuchi, K., Siatskas, C., Lee, P., Lim, H., Zhang, J., Cukerman, E., Stanford, W. L., and Medin, J. A. (2006) Stem cell factor receptor induces progenitor and natural killer cell-mediated cardiac survival and repair after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 103, 2304-2309
18. + cell proliferation and differentiation. Circ. Res. 97, e73-e83
19. Zhang, L., Qin, X., Zhao, Y., Fast, L., Zhuang, S., Liu, P., Cheng, G., and Zhao, T. C. (2012) Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J. Pharmacol. Exp. Ther. 341, 285-293
20. Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., Kasahara, H., Rota, M., Musso, E., Urbanek, K., Leri, A., Kajstura, J., Nadal-Ginard, B., and Anversa, P. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776
21. + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647-653
22. + cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ. Res. 97, 52-61
23. Oh, H., Bradfute, S. B., Gallardo, T. D., Nakamura, T., Gaussin, V., Mishina, Y., Pocius, J., Michael, L. H., Behringer, R. R., Garry, D. J., Entman, M. L., and Schneider, M. D. (2003) Cardiac progenitor cells from adult myocardium. Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. U.S.A. 100, 12313-12318
24. Smart, N., Bollini, S., Dubé, K. N., Vieira, J. M., Zhou, B., Davidson, S., Yellon, D., Riegler, J., Price, A. N., Lythgoe, M. F., Pu, W. T., and Riley, P. R. (2011) De novo cardiomyocytes from within the activated adult heart after injury. Nature 474, 640-644
25. Ellison, G. M., Torella, D., Dellegrottaglie, S., Perez-Martinez, C., Perez de Prado, A., Vicinanza, C., Purushothaman, S., Galuppo, V., Iaconetti, C., Waring, C. D., Smith, A., Torella, M., Cuellas Ramon, C., Gonzalo-Orden, J. M., Agosti, V., Indolfi, C., Galiñanes, M., Fernandez-Vazquez, F., and Nadal-Ginard, B. (2011) Endogenous cardiac stem cell activation by insulin- like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J. Am. Coll. Cardiol. 58, 977-986
26. Tseng, A., Stabila, J., McGonnigal, B., Yano, N., Yang, M. J., Tseng, Y. T., Davol, P. A., Lum, L. G., Padbury, J. F., and Zhao, T. C. (2010) Effect of disruption of Akt-1 of lin(-)c-kit(+) stem cells on myocardial performance in infarcted heart. Cardiovasc. Res. 87, 704-712
27. Cheng, K., Li, T. S., Malliaras, K., Davis, D. R., Zhang, Y., and Marbán, E. (2010) Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ. Res. 106, 1570-1581
28. Swijnenburg, R. J., Schrepfer, S., Govaert, J. A., Cao, F., Ransohoff, K., Sheikh, A. Y., Haddad, M., Connolly, A. J., Davis, M. M., Robbins, R. C., and Wu, J. C. (2008) Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc. Natl. Acad. Sci. U.S.A. 105, 12991-12996
29. Fransioli, J., Bailey, B., Gude, N. A., Cottage, C. T., Muraski, J. A., Emmanuel, G., Wu, W., Alvarez, R., Rubio, M., Ottolenghi, S., Schaefer, E., and Sussman, M. A. (2008) Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells 26, 1315-1324
30. Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A., and Anversa, P. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. U.S.A. 98, 10344-10349
31. + cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116, 1865-1877
32. Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., Entman, M. L., Michael, L. H., Hirschi, K. K., and Goodell, M. A. (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107, 1395-1402